Symbicort FDA Approval History
FDA Approved: Yes (First approved July 21, 2006)
Brand name: Symbicort
Generic name: budesonide and formoterol
Dosage form: Inhaler
Treatment for: Asthma, Maintenance, COPD, Maintenance
Symbicort (budesonide and formoterol) is a combination of a corticosteroid and a long-acting bronchodilator indicated for the long-term maintenance treatment of asthma and the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Development Timeline for Symbicort
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.